11-21-2018 01:18 PM CET - Health & Medicine
Print

Injectable Drug Delivery Market Comprehensive Analysis 2018 Developments, Product Launches: Baxter International Inc., BD, Gerresheimer, Pfizer, SCHOTT, Alkermes, Eli Lilly and Company, Sandoz, Terumo Medical Corporation, Teva Pharmaceuticals, Ypsomed AG,

Press release from: Data Bridge Market Research
Injectable Drug Delivery Market
Injectable Drug Delivery Market


Injectable Drug Delivery Market Report executes the great study of Price and Gross Margin, Capacity, Production, Revenue, current Injectable Drug Deliver Market’s geographical zones, technology, demand-supply, Consumption, Import, Export, Market Drivers and Opportunities. The report also explains in deep what the market definition, classifications, applications and market are. This research study is a valuable source of understanding data for business strategies, growth analysis, historical & futuristic cost, demand and supply data.

Global injectable drug delivery market is expected to reach USD 1,104,096.5 million by 2025 from USD 378,998.2 million in 2017, at a CAGR of 12.4% in the forecast period 2018 to 2025

By the help of SWOT analysis this report provides with a comprehensive insight about the Injectable Drug Delivery Market’s restrains and drivers all the keeping the report systematic and providing with the company profiles.

Click Here For Sample Copy of Report @: databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Market players for global injectable drug delivery market are listed below:

• Baxter International, Inc.,
• Becton Dickinson and Company,
• Gerresheimer AG,
• Pfizer, Inc.,
• Schott AG,
• Alkermes Plc.,
• Eli Lilly and Company,
• Sandoz,
• Terumo Corporation,
• Teva Pharmaceuticals Industries Ltd.
• Ypsomed,
• Bespak

BECTON, DICKINSON AND COMPANY

Founded in 1897 as Becton, Dickinson and Company and head quartered in New Jersey, U.S. is focused on developing, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. The company operates through two business segments: BD Medical and BD Life Sciences. Its medical segment business unit includes Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, and Pharmaceutical Systems. These business units’ segmentsincludeneedles and syringes, intravenous catheters, self-injection system, insulin syringes and pen needles, prefilled IV flush syringes products.

PFIZER:

Incorporated in June 1942 and headquartered in New York, U.S. Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer Inc., operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The Company’s IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients’ lives, and in addition products for the end user health care.

Its therapeutic regions incorporate oncology, antibodies, cardiovascular, metabolic, irritation, immunology, neuroscience, torment, uncommon illnesses and purchaser human services. The Company’s EH portion incorporates legacy brands that have lost or will soon lose market superiority in both rising and developed markets, biosimilars marked generics, generic sterile injectable products and mixture frameworks. EH segment additionally incorporates another EH innovative work association, and additionally contract manufacturing business.

BAXTER INTERNATIONAL:

Founded in 1931 and headquartered in Illinois, U.S., Baxter International, Inc. manufactures medical devices, pharmaceuticals, and biotechnology products. The company operates through two business segments, namely, BioScience and Medical Products. The company provides a wide range of products for the treatment of hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.

Through the Medical Products segment, the company offers intravenous solutions, administration and nutrition sets, drug reconstitution systems, prefilled syringes (with and without needles) and vials, and infusion pumps and inhalation anesthetics. On the other hand, the BioScience business segment focuses on the treatment of hemophilia and other bleeding disorders by processing recombinant and plasma-based proteins.

Have Any Query? Ask Our Expert: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Market is further segmented into:

• Type
• Usage Pattern
• End-User
• Mode of Administration
• Distribution Channel
• Application
• Geography

TABLE OF CONTENTS GLOBAL INJECTABLE DRUG DELIVERY MARKET

1. INTRODUCTION

2. MARKET SEGMENTATION

3. MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITY
3.4. CHALLENGES

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. GLOBAL INJECTABLE DRUG DELIVERY MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)

7. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY TYPE
7.1. OVERVIEW
7.2. INJECTABLE DRUG DELIVERY DEVICES
7.2.1. CONVENTIONAL INJECTION DEVICES
7.2.2. SELF INJECTION DEVICES
7.2.2.1. NEEDLE FREE INJECTORS (NFI)
7.2.2.2. AUTO INJECTORS
7.2.2.3. PEN INJECTORS
7.2.2.4. WEARABLE INJECTORS

7.3. INJECTABLE DRUG DELIVERY FORMULATION

7.3.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS

7.3.1.1. SOLUTIONS
7.3.1.2. RECONSTITUTED/LYOPHILIZED FORMULATIONS
7.3.1.3. SUSPENSIONS
7.3.1.4. EMULSIONS

7.3.2. NOVEL DRUG DELIVERY FORMULATIONS

7.3.2.1. COLLOIDAL DISPERSIONS
7.3.2.2. MICROPARTICLES
7.3.2.3. LONG ACTING INJECTION FORMULATION

8. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION

8.1. OVERVIEW
8.2. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS

8.3.1. INJECTABLE DRUGS FOR DIABETES
8.3.2. INJECTABLE DRUGS FOR ANEMIA
8.3.3. INJECTABLE DRUGS FOR REPRODUCTIVE HEALTH DISEASE
8.3.4. INJECTABLE DRUGS FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY
8.3.5. INJECTABLE DRUGS FOR OSTEOPOROSIS
8.3.6. INJECTABLE DRUGS FOR GROWTH HORMONE DISORDERS (GHD)

8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES
8.5.1. INJECTABLE DRUGS FOR RHEUMATOID ARTHRITIS
8.5.2. INJECTABLE DRUGS FOR MULTIPLE SCLEROSIS
8.5.3. INJECTABLE DRUGS FOR CROHN’S DISEASES
8.5.4. INJECTABLE DRUGS FOR PSORIASIS
8.5.5. INJECTABLE DRUGS FOR OTHER AUTOIMMUNE DISEASES

8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS
8.7.1. INJECTABLE DRUGS FOR PAIN MANAGEMENT
8.7.2. INJECTABLE DRUGS FOR ALLERGY TREATMENT
8.7.3. INJECTABLE DRUGS FOR AESTHETIC TREATMENTS
8.7.4. INJECTABLE DRUGS FOR HEPATITIS C
8.7.5. INJECTABLE DRUGS FOR HEMOPHILIA

9. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN

10. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM

11. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS

12. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.1.1. HOSPITAL PHARMACY
12.1.2. PHARMACY STORES
12.1.3. DIRECT TENDER
12.1.4. ONLINE PHARMACY

13. GLOBAL INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY
13.1. OVERVIEW
13.2. NORTH AMERICA INJECTABLE DRUG DELIVERY MARKET
13.3. EUROPE INJECTABLE DRUG DELIVERY MARKET
13.4. APAC INJECTABLE DRUG DELIVERY MARKET
13.5. SOUTH AMERICA INJECTABLE DRUG DELIVERY MARKET
13.6. MEA INJECTABLE DRUG DELIVERY MARKET

14. GLOBAL INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE

15. COMPANY PROFILES
15.1. BECTON, DICKINSON AND COMPANY
15.2. PFIZER
15.3. BAXTER INTERNATIONAL
15.4. GERRESHEIMER AG
15.5. SCHOTT AG INC.
15.6. ALKERMES INC.
15.7. ANTARES PHARMA
15.15. SANDOZ INTERNATIONAL GMBH
15.16. SANOFI

16. RELATED REPORTS

To Understand Complete Table Of Content, Tables And Figures @ databridgemarketresearch.com/toc/?dbmr=global-injectable-...

Other Market Insights:

North America injectable drug delivery market is expected to reach USD 354.5 billion by 2024 from USD 154.0 billion in 2016, at a CAGR of 11.0% in the forecast period 2017 to 2024.

Read More: databridgemarketresearch.com/reports/north-america-inject...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Sopan Gedam
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.
News-ID: 1389156 • Views: 139
More releasesMore releases

You can edit or delete your press release here: